A Review of the Clinical Applicability of Neurotrophins in Cochlear Implantation
Journal of Audiology and Otology · 20.04.2026 · 30 (2) · 93-103
DOI: 10.7874/jao.2025.00857 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Audiology and Otology, erschienen am 20.04.2026. Verfasst von Seung Cheol Ahn. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Dankook University, Cheonan, Korea. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Neurotrophins reportedly improve hearing outcomes when used in combination with cochlear implants, as they promote the survival of spiral ganglion neurons (SGNs) and stimulate SGN neurite outgrowth in animal models of sensorineural hearing loss. However, their applicability to human patients remains unknown. This review examines the clinical applicability of neurotrophins based on advances in drug delivery techniques to the inner ear and discusses their potential for future application in human patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, Dankook University, Cheonan, Korea.
Zitieren
APA
Ahn, S. C. (2026). A Review of the Clinical Applicability of Neurotrophins in Cochlear Implantation. Journal of Audiology and Otology, 30(2), 93-103. https://doi.org/10.7874/jao.2025.00857
Vancouver
Ahn SC. A Review of the Clinical Applicability of Neurotrophins in Cochlear Implantation. Journal of Audiology and Otology. 2026;30(2):93-103. doi:10.7874/jao.2025.00857
BibTeX
@article{Ahn2026,
author = {Ahn, Seung Cheol},
title = {A Review of the Clinical Applicability of Neurotrophins in Cochlear Implantation},
journal = {Journal of Audiology and Otology},
year = {2026},
volume = {30},
number = {2},
pages = {93--103},
doi = {10.7874/jao.2025.00857}
}
EUVIMED